Menin-MLL protein-protein interaction inhibitors: a patent review (2021-present)
{{output}}
Introduction: Acute leukemia harboring rearrangement of the Mixed lineage leukemia (MLL) and/or mutation of the nucleophosmin is a type of poorly prognostic and highly malignant leukemia which is extremely difficult to treat. Blo... ...
